BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2026 7:19:23 AM | Browse: 62 | Download: 216
 |
Received |
|
2025-09-23 10:33 |
|
Peer-Review Started |
|
2025-09-23 10:34 |
|
First Decision by Editorial Office Director |
|
2025-10-21 09:29 |
|
Return for Revision |
|
2025-10-21 09:29 |
|
Revised |
|
2025-11-07 18:22 |
|
Publication Fee Transferred |
|
2025-11-14 09:20 |
|
Second Decision by Editor |
|
2026-01-04 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-04 08:50 |
|
Articles in Press |
|
2026-01-04 08:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 18:37 |
|
Publish the Manuscript Online |
|
2026-02-11 07:19 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Progression after endoscopic treatment for type I gastric neuroendocrine tumors: A single-center retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ze-Liang Yang, Hui-Ke Wang, Yong Liu, Li-Zhou Dou, Yue-Ming Zhang, Hoi-Ioi Ng, Shun He, Yihe-Bali Chi and Gui-Qi Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| CAMS Innovation Fund for Medical Sciences |
2021-I2M-1-061, 2021-I2M-1-013, 2021-1-I2M-015 |
|
| Corresponding Author |
Gui-Qi Wang, Academic Fellow, MD, PhD, Professor, Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. wangguiq@126.com |
| Key Words |
Type I gastric neuroendocrine tumors; Endoscopic treatment; Neutrophil-to-lymphocyte ratio; Prognosis; Somatostatin analogues |
| Core Tip |
Endoscopic treatment is the standard therapy for type I gastric neuroendocrine tumors, but it may not address underlying disease mechanisms. In this retrospective study of 128 patients, 41 experienced progression. Multivariate Cox regression identified adjuvant somatostatin analog use as a protective factor (hazard ratio = 0.38, 95% confidence interval: 0.17-0.90, P = 0.027) and neutrophil-to-lymphocyte ratio ≥ 2 as a risk factor (hazard ratio = 2.14, 95% confidence interval: 1.08-4.26, P = 0.030). Kaplan-Meier analysis confirmed both as independent prognostic variables. These findings suggest that combining endoscopic therapy with somatostatin analogues improves outcomes. Neutrophil-to-lymphocyte ratio may serve as a simple marker to guide risk stratification. |
| Publish Date |
2026-02-11 07:19 |
| Citation |
Yang ZL, Wang HK, Liu Y, Dou LZ, Zhang YM, Ng HI, He S, Chi YB, Wang GQ. Progression after endoscopic treatment for type I gastric neuroendocrine tumors: A single-center retrospective study. World J Gastroenterol 2026; 32(8): 114268
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i8/114268.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i8.114268 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
